Paul McBarron's Insider Trades & SAST Disclosures

Paul McBarron's most recent trade in Cyclacel Pharmaceuticals Inc was a trade of 1,886 Common Stock done at an average price of $3.3 . Disclosure was reported to the exchange on Dec. 21, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cyclacel Pharmaceuticals Inc
Paul McBarron Director, See Remarks 21 Dec 2023 1,886 33,378 (0%) 0% 3.3 6,252 Common Stock
Cyclacel Pharmaceuticals Inc
McBarron Paul Director, See Remarks 21 Dec 2023 1,886 1,886 - - Warrants (right to buy)
Cyclacel Pharmaceuticals Inc
Paul McBarron Director, See Remarks 30 Jun 2023 70,200 70,200 - - Stock Option (right to buy)
Cyclacel Pharmaceuticals Inc
Paul McBarron Director, See Remarks 31 Jan 2023 31,200 31,492 (0%) 0% 0 Common Stock
Cyclacel Pharmaceuticals Inc
Paul McBarron Director, See Remarks 13 Dec 2021 100,000 100,000 - - Stock Option (right to buy)
Cyclacel Pharmaceuticals Inc
Paul McBarron Director, See Remarks 11 Dec 2020 120,000 120,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades